54152-47-5

Basic information

• Product Name: 2,2-dimethylpiperidine
• Synonyms: 2,2-dimethylpiperidine
• CAS NO: 54152-47-5
• Molecular Formula: C₇H₁₅N
• Molecular Weight: 113.2007
• EINECS: 259-002-7
• Mol File: 54152-47-5.mol

Chemical Properties

• Boiling Point: 135.8°Cat760mmHg
• Flash Point: 24.9°C
• Appearance: /
• Density: 0.803g/cm³
• Vapor Pressure: 7.6mmHg at 25°C
• Refractive Index: 1.42
• PKA: 10.82±0.10(Predicted)
• CAS DataBase Reference: 2,2-dimethylpiperidine(CAS DataBase Reference)
• NIST Chemistry Reference: 2,2-dimethylpiperidine(54152-47-5)
• EPA Substance Registry System: 2,2-dimethylpiperidine(54152-47-5)

Safety Data

• Hazardous Substances Data: 54152-47-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical and Agrochemical Synthesis:
2,2-dimethylpiperidine is used as a building block for the creation of various pharmaceuticals and agrochemicals, leveraging its reactivity to form stable intermediates that are crucial in the development of these products.
Used in Organic Chemistry as a Catalyst:
Due to its basic nature, 2,2-dimethylpiperidine is employed as a catalyst in organic chemistry reactions, enhancing the efficiency and selectivity of these processes.
Used in Rubber Compound Production:
2,2-dimethylpiperidine is utilized in the production of some rubber compounds, contributing to the properties and performance of the final rubber products.
Used as a Corrosion Inhibitor in Industrial Processes:
In industrial applications, 2,2-dimethylpiperidine serves as a corrosion inhibitor, protecting materials from degradation and extending their service life.

InChI:InChI=1/C7H15N/c1-7(2)5-3-4-6-8-7/h8H,3-6H2,1-2H3

Upstream product

• 139524-56-4 6,6-dimethyl-2-piperidinone 

Downstream Products

• 1312921-09-7 2-(1-hydroxy-6,6-dimethylpiperidin-2-yl)cyclohexane-1,3-dione 

Relevant articles and documents

Benzodiazepine derivatives

Compounds of Formula (I), and salts and prodrugs thereof, wherein R1 represents H, optionally substituted C1-6 alkyl or C3-7 cycloalkyl; R2 is NHR12 or (CH2)s R13 where 5 is 0, 1 or 2; R3 represents C1-6 alkyl, halo or NR6 R7 ; R4 and R5 are H, C1-12 alkyl optionally substituted by NR9 R9' or an azacyclic or azabicyclic group, optionally substituted C4-9 cycloalkyl, C4-9 cycloalkyl C1-4 alkyl, aryl, arylC1-6 alkyl or azacyclic or azabicyclic groups, or R4 and R5 together form the residue of an optionally substituted azacyclic or azabicyclic ring system; x is 0, 1, 2 or 3; R12 is optionally substituted phenyl or pyridyl; R13 represents a group (A) wherein R14 is H or C1-6 alkyl; R15 is H, C1-6 alkyl, halo or NR6 R7 ; and the dotted line is an optional covalent bond; are CCK and/or gastrin antagonists useful in therapy. STR1

Substituted 3-aminosyndone imines, a process for their preparation and their use

Substituted 3-aminosydnone imines of the formula I STR1 and their pharmacologically acceptable acid addition salts, in which A denotes, for example, --CH2 --, R1 denotes hydrogen or the radical --COR5, R2, R3 denote alkyl having 1 to 4 C atoms, R5 denotes, for example, an aliphatic radical having 1 to 4 C atoms, and methods for preparing such compounds by cyclization of a compound of the formula II STR2 and if desired subsequent acylation. The invention also includes formulations containing effective amounts of such compounds, and methods for administering same to patients for the control and prophylaxis of cardiovascular disorders.